Document:

<PAGE>

                                                                   Exhibit 10.25

                                                               August [  ], 2000

Mr. Craig Kussman
Executive Vice President and Chief Financial Officer
Synavant Inc.

Dear Mr. Kussman

At the Distribution Date (as defined the Synavant Inc. Form 10), IMS Health
Incorporated ("IMS") shall provide for the benefit of Permail Pty. Limited
("Permail") credit support for a letter of credit issued by a bank for up to A$4
million in favor of the Australian post office ("Postage Guarantee"). To the
extent IMS pays out any amounts with respect to such Postage Guarantee, Synavant
Inc. shall reimburse IMS in the United States the US dollar equivalent of such
amounts within five business days of demand therefor accompanied by proof of
payment. This Postage Guarantee shall terminate upon the earlier of (a) one year
from the Distribution Date or (b) the transfer by Synavant of any portion of its
interest in Permail.

James C. Malone
Chief Financial Officer
IMS Health Incorporated

Agreed and Accepted:

Craig Kussman
Executive Vice President and Chief Financial Officer
Synavant, Inc.

Cc:      Pricewaterhousecoopers
         Vickie Fash
         Wayne Yetter<PAGE>

                                                                  EXHIBIT 10.26

                                   [GRAPHIC]

                         INFORMATION SERVICES AGREEMENT

                             AGREEMENT NO.:MRS00-CON

      This Information Services Agreement ("Agreement ") is effective as of
                 ___________________ ("Effective Date") between:

                            IMS Health Incorporated,
                        North American Operations ("IMS")
                            660 West Germantown Pike
                      Plymouth Meeting, Pennsylvania 19462

                                       and

                         CLARK-O'NEILL, INC.                         ("CLIENT")
--------------------------------------------------------------------------------
                                ONE BROAD AVENUE
--------------------------------------------------------------------------------
                               FAIRVIEW, NJ 07022
--------------------------------------------------------------------------------

CLIENT hereby engages IMS to provide, and IMS agrees to provide, (a) Data, (b)
Software, (c) services to be provided by IMS to CLIENT in connection with any
Data or Software ("Services"), and (d) Documentation, subject to and in
accordance with the terms and conditions contained in this Agreement.

IMS Health Incorporated:                 Clark-O'Neill, Inc.:

By:                                      By:
   ------------------------------------     ------------------------------------

Name:                                    Name:
     ----------------------------------       ----------------------------------

Title:                                   Title:
      ---------------------------------        ---------------------------------

<PAGE>

                             IMS Health Incorporated
                         INFORMATION SERVICES AGREEMENT

1.   LICENSE
     Subject to the terms of this Agreement, IMS hereby grants to the
     interactive marketing division of CLIENT formerly known as Clark O'Neil and
     CLIENT hereby accepts, a non-exclusive, non-transferable license:
     a.    for data provided by IMS to CLIENT in any form (including
           machine-readable form) under the terms of this Agreement ("Data") as
           more specifically identified on Schedule 1 to make copies of
           insubstantial parts of Data, to modify Data and to create derivative
           works incorporating insubstantial portions of Data, all of which may
           only be used solely for CLIENT's own direct benefit and internal use
           ONLY in the United States (except that Scriptrac Data may be used in
           Canada and Australia) (unless otherwise mutually agreed to in writing
           by the parties and specifically set forth on Schedule 2) for CLIENT'S
           interactive marketing division; provided, however, Masterfile Data
           may only be used in conjunction with the Data and Services to which
           it relates (e.g., USC codes may only be used with IMS market research
           data). As used herein, the term "Masterfile Data" shall mean any Data
           which categorizes, classifies or identifies products, procedures,
           medical facilities, pharmacies, warehouses, distributors, prescribers
           or other entities, activities or persons, and any information derived
           therefrom.
     b.    for documentation and other textual and graphical material provided
           by IMS to CLIENT in any form (including printed and machine-readable
           form) relating to any Data, Software or Services ("Documentation") to
           make copies of insubstantial parts of the Documentation, to modify
           the Documentation and to create derivative works incorporating
           insubstantial portions of the Documentation, all of which may only be
           used solely for CLIENT's own direct benefit and internal use ONLY in
           the United States (except that Scriptrac Data may be used in Canada
           and Australia) (unless otherwise mutually agreed to in writing by the
           parties and specifically set forth on Schedule 2) for CLIENT'S
           interactive marketing division.
     c.    for any computer programs (i.e., any set of statements, instructions
           or objects to be used directly or indirectly in a computer in order
           to bring about a certain result) provided by IMS to CLIENT under the
           terms of this Agreement for use with any Data, hereinafter
           "Software", to operate Software in accordance with its documentation
           solely for CLIENT's own direct benefit and internal use ONLY in the
           United States for a purpose (or to achieve an effect) that is
           described in the documentation and consistent with the terms and
           conditions of this Agreement (unless otherwise mutually agreed to in
           writing by the parties and specifically set forth on Schedule 2) for
           CLIENT'S interactive marketing division. The Software may only be
           copied, in whole or in part as may be necessary and incidental to use
           on the licensed equipment, for archival and back-up purposes, or to
           replace a worn or defective copy. The license for Software shall be
           limited to executable code (unless expressly stated otherwise) and
           shall be limited to use with Data. The Software may not be reverse
           compiled, disassembled or otherwise reverse engineered. Any Data,
           Documentation or Software copied by CLIENT, in whole or in part, and
           any works derived in whole or in part from any Data or Documentation,
           shall include any copyright and proprietary notices provided by IMS
           with the respective Data, Documentation and Software and shall remain
           subject to the terms and conditions of this Agreement. CLIENT is
           expressly prohibited from sublicensing any Data, Documentation,
           Software or any information or materials derived therefrom. IMS does
           not grant, and CLIENT does not receive, any title or other interest
           in any Data, Documentation or Software except for those rights
           explicitly granted in this Agreement.
     d.    IMS does not grant, and CLIENT does not receive, an title or other
           interest in the Data or any information derived therefrom, except for
           those rights granted explicitly in this Agreement; all rights not
           expressly granted to CLIENT are reserved to IMS. Without limiting the
           generality of the foregoing, under no circumstances shall CLIENT use,
           or permit any other person or company to use, Data received by CLIENT
           in connection with this Agreement, or any information derived
           therefrom, in any manner which:

                         I.   is contrary to the terms of this Agreement or is
                              otherwise not expressly permitted by the terms of
                              this Agreement;
                         II.  will violate any law or regulation by such use;
                         III. will violate the contractual restrictions of any
                              Association identified by IMS (e.g. AMA)

<PAGE>

                              governing the use of such Association's data
                              incorporated within the Data in effect at the time
                              of the use of such Data, unless an authorized
                              representative of IMS provides CLIENT with written
                              notice that such Data is no longer subject to the
                              restrictions of such Association's agreement;
                         IV.  results in any analysis of the Data, or any
                              information derived therefrom, which analysis (i)
                              results in the disclosure to one or more persons
                              of any information regarding the mathematical
                              algorithms, formulas, processes, or projection or
                              statistical methods used by IMS to produce any of
                              the Data, (ii) is used or made available for use
                              to promote or aid in the promoting of any data or
                              information which is not derived from the Data, or
                              (iii) seeks to demonstrate that the Data, or any
                              information derived therefrom, is inferior to any
                              other data, attempts to show any deficiency in
                              such Data or information, or otherwise makes
                              statements detrimental to IMS concerning such Data
                              or information;
                         V.   results in the selection of Prescibers from whom a
                              Manufacturer, an Agency, CLIENT or any other
                              person solocits information on practice profiles
                              and/or prescribing activity for the purpose of
                              developing a database of practice and prescribing
                              profiles on individual Prescribers, except for the
                              solicitation of such information for the benefit
                              of (i) a single Manufacturer or (ii) a single
                              Healthcare Company that is a manufacturer or
                              markerer of medical supplies and/or diagnostic
                              equipment;
                         VI.  applies one or more mathematical algorithms,
                              formulas or processes to any of the Data for the
                              purpose of estimating or projecting any new data
                              or information;
                         VII. results in the reverse engineering or
                              disassembling of any of the Data; or
                         VIII. enhances, benchmarks, validates, compares with,
                              authenticates, verifies, supplements, or modifies
                              any data, products or services of CLIENT or any
                              other party except as expressly provided in this
                              Agreement.
     e.     Prior to the execution of this Agreement, CLIENT received Market
            Research Audits, software information and services from IMS. The
            terms and conditions of this Agreement including but not limited to
            Paragraph 1, 4 and 6 apply to all Market Research Audits, software
            information and services presently in CLIENT'S possession except for
            those audits, software, Scriptrac Data, information and services
            which would be covered under the Xponent License Agreement dated
            August _____, 2000.

2.   OBLIGATIONS/AUDIT RIGHTS
     a.     IMS OBLIGATIONS. IMS will provide to CLIENT the Data, Software, and
            Services described in Exhibit A hereto. IMS will also provide to
            CLIENT under the terms of this Agreement such other Data, Software
            and Services which may be ordered by CLIENT and accepted by IMS, at
            IMS's then current rates, unless subject to another formal agreement
            executed by authorized representatives of the parties. IMS will also
            provide to CLIENT all Documentation which IMS customarily makes
            available to its clients for the respective Data, Software and
            Services received by CLIENT under this Agreement. IMS will provide
            reasonable amounts of assistance in connection with CLIENT's use of
            the Data and Software. Should additional assistance be required with
            respect to any Data or Software, including formal training of any of
            CLIENT's employees, such assistance shall be at IMS's then current
            rates or at such other rates as the parties may agree upon in
            writing.
     b.     CLIENT OBLIGATIONS. From time to time, IMS may request information
            from CLIENT which IMS reasonably determines is needed to provide the
            Data, Documentation, Software or Services. Upon receipt of IMS's
            request, CLIENT shall endeavor to provide such information in its
            possession or control to IMS in a timely manner at CLIENT's expense;
            CLIENT hereby authorizes IMS to use such information in accordance
            with the terms of the request and this Agreement. Notwithstanding
            anything written in this Agreement to the contrary, CLIENT agrees to
            abide by the terms of the IMS HEALTH Policies Defining Client
            Responsibilities for Health Care Information in connection with
            CLIENT's use and disclosure of Data. In the event Data licensed by
            CLIENT under this Agreement is identified in Exhibit A as being
            subject to third party terms and conditions, CLIENT will do such
            acts and execute and deliver to IMS such further instruments as may
            be required to give effect to such third party terms and conditions.
     c.     AUDIT. IMS shall have the right to undertake an audit and inspection
            of the business, books and records of CLIENT upon five (5) days
            notice to CLIENT for purposes of verifying CLIENT'S compliance with
            it's obligations under this Agreement. CLIENT shall maintain
            business records, books, account information,

<PAGE>

            computer logs, and related materials sufficient to permit IMS to
            verify that CLIENT is in compliance with it's obligations under this
            Agreement. Any inspection of CLIENT'S books and records, shall be
            performed by IMS representatives and/or it's outside auditors. The
            cost of such an inspection shall normally be at IMS's expense.
            However, CLIENT'S shall bear the cost of an inspection and audit if
            such inspection reveals default as any other material breach of the
            terms of this Agreement.

3.   PAYMENT/PRICING
     IMS shall invoice one quarter of each annual fee identified in Exhibit A on
     a quarterly basis in advance. Each other fee identified in Exhibit A shall
     be invoiced by IMS in the manner specified in Exhibit A or, if not
     specified therein, shall be invoiced by IMS in its entirety upon the
     initial delivery of the applicable Data or Services. CLIENT shall pay the
     amount of each invoice from IMS within thirty (30) days from receipt of
     invoice by CLIENT. In no event shall CLIENT deduct or set-off any amount(s)
     against any amount(s) owed to IMS under this Agreement without IMS' prior
     written consent. If CLIENT fails to timely pay any amount in accordance
     with the terms of this Agreement, CLIENT shall pay in addition to the
     invoice amount, interest at the rate of eighteen percent (18%) per annum on
     the unpaid balance beginning thirty-five (35) days from the date of the
     invoice until such amounts are paid. In addition to any fees which CLIENT
     agrees to pay, CLIENT shall have the exclusive responsibility for and
     agrees to pay all applicable governmental sales, use, added value, ad
     valorem or other similar taxes, duties, fees, levies or other governmental
     charges now in force or enacted in the future, except for taxes based on
     IMS's income.

4.   CONFIDENTIALITY
     a.     CLIENT shall not, at any time during the term of this Agreement or
            thereafter, communicate, disclose or provide to any third party, any
            of the Data, Documentation or Software, the contents thereof, any
            information or materials derived therefrom, information relating to
            current or future IMS business plans, or any other information
            provided by IMS to CLIENT which IMS identifies on or about the time
            of its disclosure as confidential (collectively "IMS Confidential
            Information"), except as expressly provided in this Agreement or
            otherwise expressly authorized by IMS in writing. IMS shall not, at
            any time while this Agreement is in effect or thereafter,
            communicate, disclose or provide to any third party, any information
            provided by CLIENT to IMS in connection with this Agreement which
            CLIENT identifies on or about the time of its disclosure as
            confidential (collectively "Client Confidential Information"),
            except as expressly provided in this Agreement or otherwise
            expressly authorized by CLIENT in writing. Each party hereto agrees
            to treat the confidential information of the other as confidential
            using the same degree of care used by the receiving party to protect
            the receiving party's own confidential information, but in any event
            not less than a reasonable degree of care.
     b.     CLIENT may furnish all or any part of the Data to its consultants
            and independent contractors for use solely for the direct benefit of
            CLIENT, provided such consultants/independent contractors are bound
            in writing under terms and conditions which are substantially the
            same in all material respects as the terms and conditions contained
            in Paragraphs 4, 6, 7, 8, 9 and 10 of this Agreement applicable to
            CLIENT; provided, however, any use or possession of Data by
            consultants and/or independent contractors on behalf of CLIENT
            occurring OUTSIDE of offices and facilities occupied and controlled
            by CLIENT shall first require: (a) the prior express written
            approval of IMS, which approval shall not be unreasonably withheld;
            and (b) execution of an IMS Third Party Access Agreement by and
            among CLIENT, its third party, and IMS.
     c.     This Paragraph 4 does not apply to any information (i) obtained from
            an issued or registered patent, (ii) obtained from a printed
            publication distributed to more than one hundred persons in North
            America without obligation of confidentiality; (iii) independently
            developed by or on behalf of the receiving party; or (iv) disclosed
            to the receiving party without restriction by a third party not
            having an obligation of confidence with respect to such information.
            No combination of information will be deemed to be within any of the
            above exceptions, whether or not the component parts of the
            combination are within one of the above exceptions, unless the
            combination itself is within one of the above exceptions.

5.   TERM AND TERMINATION
     a.     This Agreement shall become effective as of the date written on the
            first page of this Agreement. This Agreement shall continue in
            effect through the delivery of all Data and Services identified in
            Exhibit A for

<PAGE>

            the respective periods identified therein, and payment by CLIENT
            for all such Data and Services, in accordance with the terms of this
            Agreement. Upon termination of this Agreement, Paragraphs 1, 4, 6,
            7, 8, 9 and 10 herein shall remain in effect and survive termination
            of this Agreement; provided, however, in the event this Agreement is
            terminated by IMS due to a breach by CLIENT of a material provision
            of this Agreement, CLIENT shall return to IMS all copies of Data,
            Documentation, and Software provided to CLIENT in connection with
            this Agreement which are then in CLIENT's control or possession.
     b.     IMS may terminate this Agreement and any license granted to CLIENT
            under this Agreement if (i) CLIENT fails to pay IMS any license fees
            or charges; (ii) CLIENT becomes insolvent or seeks protection,
            voluntarily or involuntarily, under any bankruptcy law; or (iii)
            upon sale of CLIENT, whether by merger, consolidation, the sale of
            it's stock or by the sales of all or substantially all of it's
            assets to a direct or indirect competitor of IMS.
     c.     In the event of any termination of this Agreement or of any license
            granted to CLIENT under this Agreement, IMS may (i) declare all
            amounts owed pursuant to this Agreement to IMS, if any, to be
            immediately due and payable; (ii) require that CLIENT cease any
            further Use of the Software, Documentation, Data or any portion
            thereof and copies of Data where termination is for cause; and/or
            (iii) cease performance of all of IMS's obligations under this
            Agreement without liability to CLIENT. Upon termination of one or
            all of the licenses granted herein for any reason, CLIENT shall
            cease usage of the specified licensed Software, Documentation or
            Data in its control or possession, along with all copies of Data
            where termination is for cause.
     d.     The rights and remedies of IMS pursuant to Paragraphs 5(b) and (c)
            above shall be cumulative and in addition to all other rights and
            remedies available to IMS in law or in equity.

6.   LIABILITY/REMEDIES
     a.     Any Data provided by IMS will reflect or be based on data and
            information provided by third parties. IMS requests from each third
            party data supplier ("Data Supplier") that the information contained
            in the Data be accurate, complete and timely. However, the Data
            Suppliers do not warrant and shall not be liable for the accuracy,
            completeness or timeliness of the Data. In addition, IMS disclaims
            any liability arising from the inaccuracy, incompleteness or late
            delivery of any Data, Documentation or Software unless due to IMS's
            willful misconduct. IMS will not be responsible for the accuracy or
            completeness of the Data, Documentation or Software due to changes
            beyond its reasonable control. In no event shall IMS be liable for
            any consequential, incidental or special damages, including but not
            limited to third party claims, whether foreseeable or not, even if
            IMS has been advised of the possibility of such damages. Any
            reliance on or decisions based on Data, Documentation, Software or
            Services is the sole responsibility of CLIENT.
     b.     The parties acknowledge and agree that a breach by either party of
            the applicable provisions of Paragraph 4 above will cause the other
            party and/or their respective affiliates irreparable injury and
            damage which may not be compensable by money damages. Therefore, the
            parties agree that the non-breaching party or its respective
            affiliates shall be entitled to injunctive or other relief to
            prevent such a breach and to secure enforcement of Paragraph 4 in
            addition to any other remedies which may be available. In the event
            this Agreement is terminated by CLIENT due to (i) a material breach
            by IMS of Paragraph 2(a) after IMS failed to cure such breach or to
            implement a mutually agreed upon plan for cure of the breach within
            thirty (30) days of receipt of written notification of such breach,
            or (ii) a material breach by IMS of Paragraph 4, CLIENT shall be
            obligated to pay only for services rendered prior to such
            termination and not yet paid to IMS pursuant to this Agreement. In
            the event of termination of this Agreement due to a material breach
            by CLIENT of Paragraph 4, CLIENT shall be obligated to pay (x) the
            unpaid fees for any Data, Documentation, Software or Services
            delivered to CLIENT under this Agreement prior to termination, and
            (y) the unpaid fees for any Data, Documentation, Software or
            Services to be delivered in the six months immediately following
            such termination. Nothing in this Paragraph 6 shall be construed as
            limiting the legal rights otherwise available to either party in the
            event of a breach of this Agreement by the other party. All
            remedies, fee reductions, penalties and credits which may be
            available to either party in the event of a breach of this Agreement
            by the other party, whether or not enumerated in this Agreement,
            shall be cumulative.

7.   REPRESENTATIONS AND WARRANTIES
     a.     CLIENT and IMS represent and warrant that they each have authority
            to enter into this Agreement and to grant the rights and license(s)
            provided herein.
     b.     IMS further warrants for a period of sixty (60) days from CLIENT's
            receipt, that all Data provided under this Agreement will conform to
            the applicable IMS published specifications prevailing at the time
            of

<PAGE>

            shipment. IMS's entire liability and CLIENT's exclusive remedy for
            any breach of this warranty shall be for IMS to endeavor to correct,
            in accordance with IMS's operating procedures for data quality
            assurance, any such non-conformance which has been properly reported
            by CLIENT to IMS in writing within such sixty day period.
     c.     IMS further warrants that the media upon which any Data,
            Documentation or Software resides when delivered to CLIENT shall be
            free from defects in material and workmanship for a period of sixty
            days after CLIENT's receipt. IMS's entire liability and CLIENT's
            exclusive remedy for any breach of this warranty is to replace the
            defective media, provided that CLIENT notifies IMS in writing of
            such defect and returns to IMS the defective media during such sixty
            day warranty period.
     d.     ALL THIRD PARTY DATA, DOCUMENTATION AND SOFTWARE WHICH MAY BE
            PROVIDED BY IMS TO CLIENT IN CONNECTION WITH THIS AGREEMENT IS
            PROVIDED ON AN "AS-IS" BASIS, WITHOUT ANY WARRANTIES OF ANY KIND,
            OTHER THAN THOSE AVAILABLE TO CLIENT FROM THE RESPECTIVE THIRD
            PARTY, IF ANY.
     e.     THE WARRANTIES AND REPRESENTATIONS STATED WITHIN THIS AGREEMENT ARE
            EXCLUSIVE, AND IN LIEU OF ALL OTHER WARRANTIES, EXPRESS OR IMPLIED,
            INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR
            A PARTICULAR PURPOSE. IMS does not warrant that any Data,
            Documentation, Software or Services provided by IMS to CLIENT will
            meet the needs or objectives of CLIENT; CLIENT assumes sole
            responsibility for its use, selection, and the suitability of the
            Data, Documentation, Software and Services provided by IMS to CLIENT
            to meet the needs and objectives of CLIENT.

8.   ASSIGNMENT

     Neither party may assign or transfer this Agreement or any of their
     respective rights or obligations in connection with this Agreement to any
     third party without the express written consent of the other party. CLIENT
     may not transfer or sublicense any Data, Documentation or Software to any
     third party without the express written consent of IMS. Any attempt to
     assign, transfer or sublicense in breach of the foregoing shall be void.
     Notwithstanding the prohibition in the previous two sentences of this
     paragraph, IMS shall have the right to assign its rights and obligations
     under this Agreement to any of its subsidiaries and affiliates, provided
     that no such assignment shall relieve IMS of its obligations in this
     Agreement if the assignee fails to perform. In addition, IMS shall have a
     right to assign this Agreement (including by operation of law) to the
     surviving party of any merger, acquisition, or reorganization to which it
     is a party, or sale of all or substantially all of IMS assets. IMS agrees
     to promptly notify the CLIENT in writing of any such assignment on or about
     the time of its occurrence. This Agreement shall be binding upon and shall
     inure to the benefit of the parties and any of their successors, and any
     such successor shall be deemed substituted for the respective party under
     the provisions of this Agreement. For the purposes of this Agreement, the
     term "successor" shall mean any person, firm, corporation or other business
     entity which at any time, whether by merger, acquisition, or otherwise,
     acquires all or substantially all of the assets or business of a party to
     this Agreement.

9.   NOTICE
All notices, demands or other communications required solely in connection with
this Agreement shall be given and made in writing and shall be delivered
personally or sent pre-paid to the respective addresses set forth on the first
page of this Agreement (a) by certified or registered first class mail with
return receipt requested or (b) by an internationally-recognized common
carrier's overnight courier service (e.g., Airborne's Express One / Express
Pack). If such notice is to IMS, the notice shall be sent to the attention of
"Vice President, Sales". If such notice is sent to CLIENT, the notice shall be
sent to the attention of: Vice President, Finance ______________________.

10.  MISCELLANEOUS
     a.     ENTIRE AGREEMENT. This Agreement and the attachments hereto
            constitute all of the terms and conditions with respect to the
            subject matter of this Agreement and supersede prior proposals,
            agreements and representations related to the terms and conditions
            described herein, whether written or oral. No modifications,
            amendments or waiver of any of the provisions of this Agreement
            shall be binding upon the parties unless made in writing and duly
            executed by authorized representatives of CLIENT and IMS. This
            Agreement may be executed in one or more counterparts, each of which
            shall be deemed an original, and all of which together shall
            constitute one and the same document. This Agreement shall take
            precedence

<PAGE>

            over CLIENT's additional or different terms and conditions, to which
            notice of objection is hereby given. Neither IMS's commencement of
            performance nor delivery shall be deemed or construed as acceptance
            of CLIENT's additional or different terms and conditions. The
            headings of the paragraphs of this Agreement are used for
            convenience only and shall not affect the meaning or interpretation
            of the terms and conditions of this Agreement.
     b.     FORCE MAJEURE. Except for the obligation to pay money properly due
            and owing, either party shall be excused from any delay or failure
            in performance hereunder caused by reason of any occurrence or
            contingency beyond its reasonable control, including, but not
            limited to, failure of performance by the other party, earthquake,
            labor disputes, riots, governmental requirements or actions,
            inability to secure materials on a timely basis, failure of computer
            equipment, failures or delays of sources from which information or
            data is obtained and transportation difficulties.
     c.     WAIVER/SEVERABILITY. The failure to enforce at any time the
            provisions of this Agreement or to require at any time performance
            by the other party of any of the provisions of this Agreement shall
            in no way be construed to be a waiver of such provisions or to
            affect either the validity of this Agreement, or the right of any of
            the parties thereafter to enforce each and every provision in
            accordance with the terms of this Agreement. If any provision of
            this Agreement is held to be invalid or unenforceable by any
            judgment of a tribunal of competent jurisdiction, the remainder of
            such agreement shall not be affected by such judgment, and such
            agreement shall be carried out as nearly as possible according to
            its original terms and intent. However, if the original intent of
            the parties cannot be preserved, this Agreement shall terminate upon
            the effective date of such judgment.
     d.     GOVERNING LAW. This Agreement will be governed by the laws of the
            Commonwealth of Pennsylvania without regard to its conflict of law
            rules.
     e.     PUBLICITY. Neither party will originate any written publicity, news
            release, or other public announcement relating to this Agreement
            without the prior written approval of the other party; provided,
            however, either party shall have the right to announce to the public
            the existence of this Agreement, the general nature of services to
            be provided (e.g., market research services, sales management
            services), and the duration of this Agreement. No publicity, press
            release or public announcement by IMS shall indicate CLIENT is
            endorsing any of the IMS Data, Documentation, Software or Services
            without the express written consent of CLIENT.
     f.     CLIENT DATA. Client Data refers to certain data provided by CLIENT
            to IMS relating to direct sales of CLIENT's pharmaceutical products
            by CLIENT to its customers. Client Data includes elements of data
            reflecting CLIENT's weekly/monthly sales of pharmaceutical products
            made to any unaffiliated party. In order to receive access to Sales
            Management Information Services from IMS, CLIENT agrees to submit
            Client Data. IMS will handle Client Data in accordance with
            Paragraph 4 of this Agreement, subject to the restrictions outlined
            in this paragraph. IMS may only use Client Data as follows: (i) for
            inclusion, where applicable, in the collection of Data processes and
            provided to CLIENT under this Agreement; and (ii) for use in any of
            IMS's reports and services, provided such use is in a form that
            masks the source of the Client Data (i.e., the Client Data must be
            converted, standardized and merged with the data of third parties).
            Without limiting IMS's rights under the preceding sentence, IMS may,
            for example, use Client Data for the calculation and reporting of
            (a) total market values (i.e., the combination of indirect, mail
            order and/or direct sales distribution) and (b) direct sales totals
            and indices (i.e., the combination of direct sales data from various
            pharmaceutical companies) for the benefit of IMS's clients; provided
            IMS ensures that CLIENT's direct sales data is converted and
            standardized by IMS so that CLIENT is not identified as the source
            of the data.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}]]